![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Purpose
The aim of this study was to report a patient who developed a full‐thickness macular hole following intravitreal bevacizumab injection.
Methods
A 78‐year‐old patient diagnosed with choroidal neovascularisation (CNV) was treated with intravitreal bevacizumab injection.
Results
On the first follow‐up visit, a decrease in visual acuity was seen and a small full‐thickness macular hole with complete resolution of subretinal fluid was observed in optical coherence tomography (OCT). A second intravitreal injection of bevacizumab was performed. At the subsequent visit, a serious loss of visual acuity and limited regression in choroidal neovascularisation was seen. The OCT showed a larger full‐thickness macular hole.
Conclusions
This case demonstrates that intravitreal bevacizumab injection might be responsible for the development of a macular hole. Clinicians should be cautious that a macular hole may be a complication of intravitreal bevacizumab injection.
This manuscript was presented as a poster presentation at the XVI Afro‐Asian Congress of Ophthalmology and the V Mediterranean Retina Meeting, 13–16 June 2012, Istanbul.
This manuscript was presented as a poster presentation at the XVI Afro‐Asian Congress of Ophthalmology and the V Mediterranean Retina Meeting, 13–16 June 2012, Istanbul.
Notes
This manuscript was presented as a poster presentation at the XVI Afro‐Asian Congress of Ophthalmology and the V Mediterranean Retina Meeting, 13–16 June 2012, Istanbul.